Bank of Montreal’s Quantum Biopharma Class B Subordinate Voting Shares QNTM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
Sell
-172
Closed -$2.41K 4317
2024
Q2
$2.41K Sell
172
-6
-3% -$146 ﹤0.01% 3765
2024
Q1
$9.51K Buy
+178
New +$9.75K ﹤0.01% 3696
2021
Q2
Sell
-12
Closed -$1K 5015
2021
Q1
$1K Sell
12
-8
-40% -$1.12K ﹤0.01% 5009
2020
Q4
$3K Sell
20
-4
-17% -$472 ﹤0.01% 4816
2020
Q3
$4K Sell
24
-1
-4% -$208 ﹤0.01% 4536
2020
Q2
$6K Hold
25
﹤0.01% 4390
2020
Q1
$6K Buy
+25
New +$8.28K ﹤0.01% 3649

Other funds holding QNTM

Bank of Montreal's QNTM Position: Q3 2024 in Review

Bank of Montreal sold out of Quantum Biopharma Class B Subordinate Voting Shares (QNTM) in Q3 2024, closing a stake of 172 shares — an estimated $2.41K sold.

Bank of Montreal first reported a position in QNTM in Q1 2020 and held it in 7 quarters. The position peaked at $9.51K in Q1 2024. 12 funds tracked by Wall St. Rank hold QNTM as of Q3 2024.

  • Bank of Montreal reported no remaining Quantum Biopharma Class B Subordinate Voting Shares position as of Q3 2024 after selling out during the quarter.
  • Bank of Montreal sold 172 Quantum Biopharma Class B Subordinate Voting Shares shares in Q3 2024, an estimated $2.41K.
  • Bank of Montreal first reported a position in Quantum Biopharma Class B Subordinate Voting Shares in Q1 2020 and held it in 7 quarters.
  • Bank of Montreal's Quantum Biopharma Class B Subordinate Voting Shares position peaked at $9.51K in Q1 2024.
  • 12 funds tracked by Wall St. Rank held Quantum Biopharma Class B Subordinate Voting Shares as of Q3 2024.

Based on Bank of Montreal's 13F filing for Q3 2024, filed 13 Nov 2024.